Zobrazeno 1 - 10
of 348
pro vyhledávání: '"Sarolta Kárpáti"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Laura Vízkeleti, Orsolya Papp, Viktória Doma, Jeovanis Gil, György Markó-Varga, Szonja A. Kovács, Balázs Győrffy, Sarolta Kárpáti, József Tímár
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-16 (2024)
Abstract Malignant melanoma is a difficult-to-treat skin cancer with increasing incidence worldwide. Although type-I interferon (IFN) is no longer part of guidelines, several melanoma patients are treated with type-I interferon (IFN) at some point of
Externí odkaz:
https://doaj.org/article/c19738d85de242578f64a9a66457ea73
Publikováno v:
Journal of the European Academy of Dermatology & Venereology. May2022, Vol. 36 Issue 5, p637-640. 4p.
Autor:
S. Kárpáti
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV. 36(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71475bd79de2edc9366b5d975b8610a4
https://pubmed.ncbi.nlm.nih.gov/35416365
https://pubmed.ncbi.nlm.nih.gov/35416365
Autor:
Uğur Çakır, Petra Balogh, Anikó Ferenczik, Valentin Brodszky, Tibor Krenács, Sarolta Kárpáti, Miklós Sárdy, Péter Holló, Melinda Fábián
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
Melanoma incidence is increasing globally. Although novel therapies have improved the survival of primary melanoma patients over the past decade, the overall survival rate for metastatic melanoma remains low. In addition to traditional prognostic fac
Externí odkaz:
https://doaj.org/article/a477810b7a474039969f558aba46fbf1
Autor:
Leticia Szadai, Aron Bartha, Indira Pla Parada, Alexandra I.T. Lakatos, Dorottya M.P. Pál, Anna Sára Lengyel, Natália Pinto de Almeida, Ágnes Judit Jánosi, Fábio Nogueira, Beata Szeitz, Viktória Doma, Nicole Woldmar, Jéssica Guedes, Zsuzsanna Ujfaludi, Zoltán Gábor Pahi, Tibor Pankotai, Yonghyo Kim, Balázs Győrffy, Bo Baldetorp, Charlotte Welinder, A. Marcell Szasz, Lazaro Betancourt, Jeovanis Gil, Roger Appelqvist, Ho Jeong Kwon, Sarolta Kárpáti, Magdalena Kuras, Jimmy Rodriguez Murillo, István Balázs Németh, Johan Malm, David Fenyö, Krzysztof Pawłowski, Peter Horvatovich, Elisabet Wieslander, Lajos V. Kemény, Gilberto Domont, György Marko-Varga, Aniel Sanchez
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionWhile Immune checkpoint inhibition (ICI) therapy shows significant efficacy in metastatic melanoma, only about 50% respond, lacking reliable predictive methods. We introduce a panel of six proteins aimed at predicting response to ICI ther
Externí odkaz:
https://doaj.org/article/fe95ef6a509c4265b300a1ff4e58f88f
Autor:
Krzysztof Sitko, Sarolta Kárpáti, Grzegorz Węgrzyn, Grzegorz Mincewicz, Magdalena Trzeciak, Michael Kasperkiewicz, Stefan Tukaj
Publikováno v:
Frontiers in Medicine, Vol 10 (2024)
Heat shock protein 90 alpha (Hsp90α) is one of the key intra- and extracellular chaperones responsible for the biological activity of various signaling molecules that are involved in (auto)immune-mediated inflammatory diseases. Recent epidemiologic
Externí odkaz:
https://doaj.org/article/9fc912abf4204c8ab6f0d0a8963215aa
Autor:
Veronika Tóth, Stefani Christina Diakoumakou, Enikő Kuroli, Béla Tóth, Daniella Kuzmanovszki, József Szakonyi, Kende Kálmán Lőrincz, Beáta Somlai, Sarolta Kárpáti, Péter Holló
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe possible correlation between melanoma and Parkinson’s disease (PD) has been intensively studied. In this work, we aimed to assess the coincidence of skin malignancies and PD at a dermato-oncological university centre in Central-Easter
Externí odkaz:
https://doaj.org/article/ab5bbf09412946489dde435f5a931908
Autor:
Éva Áy, Viktor Müller, Mária Mezei, Ágnes Pocskay, Anita Koroknai, Dalma Müller, Zoltán Győri, Márta Marschalkó, Béla Tóth, Sarolta Kárpáti, Botond Lakatos, János Szlávik, Mária Takács, János Minárovits
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 20, Iss , Pp 124-130 (2020)
Objectives: Transmitted human immunodeficiency virus type 1 (HIV-1) drug resistance (TDR) may affect the success of first-line antiretroviral treatment. This study aimed to monitor the presence of HIV-1 strains carrying transmitted drug resistance-as
Externí odkaz:
https://doaj.org/article/750d697715474280a440e5ad66f5cfc2
Autor:
Takashi Hashimoto
Publikováno v:
Nishi Nihon Hifuka. 70:569-570
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7938b021128ff726775b2b841b921e4e
https://doi.org/10.2336/nishinihonhifu.70.569
https://doi.org/10.2336/nishinihonhifu.70.569